2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$27.05-$0.13 (-0.50%)
Price as of Jun 03, 2026 7:50 PM EDT- $484.4MMarket Cap
- 167.49%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$27.05-$0.13 (-0.50%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 102.5M +65.18% | 62.0M -59.64% | 153.7M +126.84% | 67.8M +9.52% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 102.5M +65.18% | 62.0M -59.64% | 153.7M +126.84% | 67.8M +9.52% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -166.4M -33.97% | -252.0M +39.69% | -180.4M +31.53% | -137.2M +31.39% | |
Depreciation and Amortization Expense | 7.3M +1.47% | 7.2M +5.90% | 6.8M +19.79% | 5.7M +17.46% | |
Total Operating Expenses | 260.9M -13.19% | 300.5M +23.66% | 243.0M +23.53% | 196.7M +22.64% | |
Operating Profit | -158.4M -33.59% | -238.5M +167.09% | -89.3M -30.76% | -128.9M +30.87% | |
Interest Income | 9.3M -50.38% | 18.6M +28.48% | 14.5M +319.97% | 3.5M +498.79% | |
Interest Expense | N/A N/A | N/A N/A | -1.3M -45.83% | -2.4M -7.69% | |
Interest Income and Expense and Net | 9.3M -50.38% | 18.6M +41.13% | 13.2M +1,152.13% | 1.1M +152.15% | |
Total Nonoperating Income and Expense | -32.8M -345.69% | 13.4M N/A | N/A N/A | N/A N/A | |
Income before Taxes | -191.2M -15.07% | -225.1M +154.06% | -88.6M -24.08% | -116.7M +18.45% | |
Income Taxes | -93,000 -103.94% | 2.4M -87.01% | 18.2M +627.68% | 2.5M N/A | |
Extraordinary Items | 1.7M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -191.1M -15.99% | -227.5M +112.99% | -106.8M -10.41% | -119.2M +12.95% | |
Net Income from Continuing Operations Applicable to Common | -191.2M -15.07% | -225.1M +154.06% | -88.6M -24.08% | -116.7M +10.58% | |
Basic EPS and Net Income | -22.49 +659.80% | -2.96 +66.29% | -1.78 -24.26% | -2.35 +2.62% | |
Diluted EPS and Net Income | -22.49 +659.80% | -2.96 +66.29% | -1.78 -24.26% | -2.35 +2.62% | |
Basic Weighted Average Shares | 8.5M -88.94% | 76.8M +27.70% | 60.2M +18.57% | 50.7M +10.02% | |
Diluted Weighted Average Shares | 8.5M -88.94% | 76.8M +27.70% | 60.2M +18.57% | 50.7M +10.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 58.1M -69.45% | 190.3M +174.74% | 69.3M +46.59% | 47.3M +55.37% | |
Short-Term Investments | 83.3M -34.20% | 126.6M -52.12% | 264.4M +3.65% | 255.1M +95.71% | |
Cash and Cash Equivalents and Short-Term Investments | 141.4M -55.37% | 316.9M -5.03% | 333.7M +10.36% | 302.3M +88.08% | |
Total Current Assets | 150.9M -56.04% | 343.3M -18.56% | 421.5M +19.37% | 353.2M +61.61% | |
Accumulated Depreciation | 27.4M -43.75% | 48.6M +15.34% | 42.2M +11.23% | 37.9M +13.40% | |
Property and Plant and Equipment and Net | 10.6M -41.46% | 18.2M -17.09% | 21.9M -10.89% | 24.6M +9.18% | |
Total Long-Term Assets | 495,000 -93.10% | 7.2M +101.07% | 3.6M +92.29% | 1.9M +12.08% | |
Total Assets | 173.8M -55.11% | 387.2M -17.74% | 470.7M +15.68% | 406.9M +19.20% | |
Income Taxes Payable | 0 -100.00% | 18,000 -99.88% | 15.2M N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 4.1M 0.00% | 4.1M -67.51% | 12.5M +33.33% | |
Total Current Liabilities | 75.1M -43.03% | 131.9M +40.69% | 93.7M +40.87% | 66.5M +59.45% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 3.8M -76.04% | |
Total Long-Term Liabilities | 1.7M 0.00% | 1.7M 0.00% | 1.7M +1,323.53% | 119,000 -18.49% | |
Total Liabilities | 306.3M -10.60% | 342.6M +6.70% | 321.1M +69.09% | 189.9M +113.74% | |
Retained Earnings | -978.0M +24.28% | -786.9M +40.66% | -559.4M +23.59% | -452.6M +35.75% | |
Total Stockholders Equity | -132.5M -396.97% | 44.6M -70.20% | 149.6M -31.05% | 217.0M -14.06% | |
Total Shares Outstanding | 8.6M -89.60% | 82.5M +35.27% | 61.0M +6.10% | 57.5M +24.12% | |
Cash Flow | |||||
Cash from Operating Activities | -177.2M -7.47% | -191.5M +71.61% | -111.6M -3,245.00% | 3.5M +104.35% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 45.0M -79.40% | 218.5M +5,668.50% | -3.9M -88.80% | -35.0M -64.01% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 44,000 -99.95% | 94.1M -31.62% | 137.6M +184.71% | 48.3M +1,383.81% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -154.53% -59.79% | -384.34% +561.80% | -58.07% -69.48% | -190.26% +19.50% | |
Return on Assets | -68.12% +28.47% | -53.02% +117.89% | -24.34% -23.61% | -31.86% +11.01% | |
Return on Equity | 435.02% +285.75% | -234.19% +302.08% | -58.25% +14.73% | -50.77% +40.61% | |
Revenue Growth | 65.18% +209.29% | -59.64% -147.02% | 126.84% +1,232.07% | 9.52% -78.77% | |
Current Ratio | 2.01 -22.82% | 2.60 -42.11% | 4.50 -15.27% | 5.31 +1.36% | |
Cash Ratio | 0.77 -46.38% | 1.44 +95.28% | 0.74 +4.06% | 0.71 -2.55% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.03 -63.87% | 0.08 -24.55% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.009 -78.50% | 0.04 -45.65% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow